Biometric monitoring devices for assessing end points in clinical trials: Developing an ecosystem

Stephen P. Arneric, Jesse M. Cedarbaum, Sean Khozin, Spyros Papapetropoulos, Derek L. Hill, Michael Ropacki, Jane Rhodes, Penny A. Dacks, Lynn D. Hudson, Mark Forrest Gordon, Volker D. Kern, Klaus Romero, George Vradenburg, Rhoda Au, Daniel R. Karlin, Maurizio F. Facheris, Cheryl J. Fitzer-Attas, Ottavio V. Vitolo, Jian Wang, Bradley M. MillerJeffrey Kaye

Research output: Contribution to journalLetter

13 Scopus citations
Original languageEnglish (US)
Number of pages1
JournalNature Reviews Drug Discovery
Volume16
Issue number10
DOIs
StatePublished - Oct 1 2017

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Arneric, S. P., Cedarbaum, J. M., Khozin, S., Papapetropoulos, S., Hill, D. L., Ropacki, M., Rhodes, J., Dacks, P. A., Hudson, L. D., Gordon, M. F., Kern, V. D., Romero, K., Vradenburg, G., Au, R., Karlin, D. R., Facheris, M. F., Fitzer-Attas, C. J., Vitolo, O. V., Wang, J., ... Kaye, J. (2017). Biometric monitoring devices for assessing end points in clinical trials: Developing an ecosystem. Nature Reviews Drug Discovery, 16(10). https://doi.org/10.1038/nrd.2017.153